BLOG

ADASTRA LABS ANNOUNCES DIRECTOR RESIGNATION

ADASTRA LABS ANNOUNCES DIRECTOR RESIGNATION LANGLEY, BC / MARCH 29, 2021 – ADASTRA LABS ANNOUNCES DIRECTOR RESIGNATION F Blaine Bailey has resigned as a director of …

READ MORE

PHYTO EXTRACTIONS(TM) (ADASTRA LABS) LAUNCHES NEW SHATTER PRODUCT LINE TO CANADIAN RETAIL MARKET IN TIME FOR 420

PHYTO RELEASES THREE CANNABIS SHATTER PRODUCTS LANGLEY, BC / APRIL 09, 2021 – PHYTO EXTRACTIONS(TM) (ADASTRA LABS) LAUNCHES NEW SHATTER PRODUCT LINE TO CANADIAN RETAIL …

READ MORE

ADASTRA LABS ANNOUNCES NAME CHANGE TO PHYTO EXTRACTIONS INC. & SHARE CONSOLIDATION

ADASTRA LABS TO CHANGE NAME TO PHYTO APRIL 7 LANGLEY, BC / APRIL 05, 2021 – ADASTRA LABS ANNOUNCES NAME CHANGE TO PHYTO EXTRACTIONS INC. …

READ MORE

ADASTRA LABS ANNOUNCES PHYTO EXTRACTIONS(TM) ACQUISITION UPDATE; FINANCING; AND CORPORATE RE-BRANDING & CONSOLIDATION

ADASTRA CONTINUES TO WORK TOWARD CLOSING PHYTO DEAL LANGLEY, BC / March 29, 2021 – ADASTRA LABS ANNOUNCES PHYTO EXTRACTIONS(TM) ACQUISITION UPDATE; FINANCING; AND CORPORATE …

READ MORE

ADASTRA LABS PROVIDES CORPORATE UPDATE: MANAGEMENT CHANGE AND ACQUISITION

ADASTRA LABS PROVIDES CORPORATE UPDATE: MANAGEMENT CHANGE AND ACQUISITIONLANGLEY, BC / ISSUEWIRE / March 10, 2021 – Adastra Labs (2019) Inc . (CSE: XTRX) (FRANKFURT: …

READ MORE

Proactive Investors Interview: Setting up 2021 with Phyto Extractions and Joyn Botanicals

Speaking with Proactive Investors’ Steve Darling, Adastra CEO Andy Hale shared why 2021 is off to an amazing start for our team and partners. The …

READ MORE

Adastra Expands to Provide BHO while Inking Terms with Phyto Extractions as the Brand’s Quarter on Quarter Revenue Doubles in Q3 2020

LANGLEY, BC / ACCESSWIRE / December 23, 2020 – Adastra Labs Inc. (CSE: XTRX)  (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing …

READ MORE

Adastra Signs Joint Venture Agreement with JOYN Botanicals to Solidify Cannabis 3.0 Edible and Beverage Technology Partnership

LANGLEY, BC / ACCESSWIRE / December 18, 2020 – Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical testing …

READ MORE

Proactive Investors interview with Adastra CEO Andy Hale: Strong Q3 revenue and Solargram agreement

In this video interview with Steve Darling at Proactive Investors, our CEO Andy shares our strong Q3 2020 revenue and our recent processing agreement with …

READ MORE

Adastra Near-Doubles Quarter on Quarter Revenue and Reports Financial Results for the Q3 2020

LANGLEY, BC / ACCESSWIRE / December 14, 2020 –  Adastra Labs Inc. (CSE: XTRX) (FRANKFURT: D2EP) (“Adastra”) a Health Canada Licensed cannabis processing and analytical …

READ MORE
Scroll to Top

KEEP UP TO DATE

SIGN UP FOR OUR NEWSLETTER